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DISCUSSION

CASE REPORT

INTRODUCTION
•	Epstein Barr Virus (EBV) positive mucocutaneous
ulcers (MCU) were first described in 2010 in
immunosuppressed patients occurring in the
1
mouth, skin, and GI tract
•	Lesions are described as shallow, sharply
2
circumscribed mucosal or cutaneous ulcers
			 −	Histology notes polymorphous infiltrates of
lymphocytes and immunoblasts with EBER1-positive
2
features
•	Typically EBVMCU are treated conservatively, and
1,2,3
resolve with reversal of immunosuppression
•	Some reports have described an association with
disseminated Hodgkin’s Lymphoma and diffuse
2,3
large B-cell lymphomas (DLBCL)
•	We report a case of an EBVMCU discovered in an
immunocompentent patient superimposed with
acute campylobacter colitis with serologic evidence
of recent EBV infectious mononucleosis

•	A 47 year-old male with no PMH presented with
a 1-month history of bloody diarrhea with a
recent development of pharyngitis with flu-like
symptoms 1 week prior
•	Physical exam noted pharyngeal erythema,
symmetrical bilateral cervical lymphadenopathy,
and diffuse abdominal tenderness
•	Admission labs were significant for a normal
hemoglobin, leukocytosis with a lymphocytic
predominance, and LFT abnormalities
•	CT of his abdomen and pelvis revealed
circumferential rectal wall thickening with
stranding in the setting of diffuse abdominal
lymphadenopathy, splenomegaly, and multiple
hepatic lesions. Radiographically concerning for
malignancy

•	Serum AFP, CEA, CA 19-9 were within normal
limits. HIV screen were negative. Fecal
calprotectin was noted to be over 830ug/g
•	Further evaluation with a hepatic MRI noted
liver cysts. Stool cultures were positive for
Campylobacter
•	He was treated with azithromycin however
symptoms persisted
•	Colonoscopy revealed several clean-based ulcers
within the rectum and sigmoid colon (Figure 1)
•	Biopsies were positive for EBVMCU (Figure 2).
Serum EBV serologies indicated recent EBV
infection
•	Symptoms eventually improved and patient
was discharged in stable condition with
recommended outpatient follow-up

•	As of April 2016, 51 cases of EBVMCU has been described in the literature
			 −	5 cases described colonic involvement
•	All reports have been associated with immunosuppression by either
2
medication or age-related immunosenescence in patients over the age of 60
•	The majority of cases were self-limited and resolved with reversal of
immunosuppression. Rare cases were treated with Rituximab or with surgical
resection. One case was treated with chemotherapy (R-CHOP) however all
3
cases reported complete remission
•	Described here is a rare case in which a colonic EBVMCU was discovered
within a young otherwise healthy male during acute campylobacter colitis
with serologic evidence of recent infectious mononucleosis
•	Although in previous literature, EBVMCU were reported to fall within the
spectrum of EBV-associated proliferative disorders, the 2016 WHO update
of the classification of lymphoid neoplasms have recognized EBVMCU as a
separate entity from EBV positive DLBCL due to their observed self-limited
2,4
growth and response to conservative management
2
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Figure 1: Colonoscopy acquired images depicting several clean based rectal ulcers

Figure 2: (Left) H&E stain of rectal ulcer noting colonic mucosa with dense
lymphoplasmacyctic infiltrate. (Right) EBV in situ hybridization indicating presence of
EBV DNA within the nuclei of infected cells.

